In embodiments there is described a cardiovascular tube-shaped lockable and expandable bioabsorbable scaffold having a low immunogenicity manufactured from a crystallizable bioabsorbable polymer composition or blend.

The present invention relates to an implantable apparatus and methods of use thereof for treating congestive heart failure. An apparatus of this invention may be anchored by implantation of a section of the apparatus within in a branch pulmonary artery, for example the left pulmonary artery, which then positions and anchors another section, for example a device frame section of the apparatus within the main pulmonary artery. A medical device may be attached to the anchored device frame.

The invention is directed to an expandable stent for implanting in a body lumen, such as a coronary artery, peripheral artery, or other body lumen. The invention provides for an intravascular stent having a plurality of cylindrical rings connected by undulating links. The stent has a high degree of flexibility in the longitudinal direction, yet has adequate vessel wall coverage and radial strength sufficient to hold open an artery or other body lumen. The stent can be compressed or crimped onto a catheter to a very low profile since the peaks that are adjacent the curved portion of the undulating link are shorter than other peaks in the same cylindrical ring to prevent overlap yet still achieve a very low profile, tightly crimped stent onto a catheter.

The present invention relates to a thoracic aortic covered stent (100), comprising a bare stent segment (110) and a covered stent segment (120). The bare stent segment (110) comprises a bare wave-shaped ring (111); the covered stent segment (120) has a lesser curvature side region (100c), a greater curvature side region (100a), and two opposite intermediate regions (100b) located between the lesser curvature side region (100c) and the greater curvature side region (100a) respectively; and the covered stent segment (120) comprises a first proximal wave-shaped ring (121). The stent (100) further comprises a first connecting member (131), a first side connecting member (132) and a second side connecting member (133) all connected to the bare wave-shaped ring (111) and the first proximal wave-shaped ring (121), wherein the first connecting member (131) is arranged in the lesser curvature side region (100c), and the first side connecting member (132) and the second side connecting member (133) are arranged in the two intermediate regions (100b) respectively. The stent (100) when located near the lesser curvature side (22) with a relatively small radius of curvature has a connecting assembly rigidly connecting the bare stent segment (110) and the covered stent segment (120), and through the constraints thereof, the bare stent segment (110) can be effectively prevented from overturning towards the vessel wall during the release process, so that the proximal end of the covered stent segment (120) is securely apposed to the wall, thereby avoiding the turnover effect.

A stent formed by slitting a tube to create a matrix of struts, the slitted tube being radially expandable to a stenting disposition in which the struts exhibit a zig-zag pattern in successive loops around the circumference of the stent, the zig-zag pattern exhibiting a cusp between any two adjacent struts, with selected tied cusps of any one loop being connected by a bridge to a facing cusp of the adjacent loop and with intervening free cusps, characterized by lengthwise staggering of circumferentially adjacent said slits within said loops, wherein any two struts that are contiguous with a said tied cusp are of different lengths and any strut that extends from one free cusp to another free cusp has the same length as any other such strut such that, in the said stenting disposition, the free cusps of adjacent loops are circumferentially displaced from each other.

Bioabsorbable scaffolds having high crush recoverability, high fracture resistance, and reduced or no recoil due to self expanding properties at physiological conditions are disclosed. The scaffolds are made from a random copolymer of PLLA and a rubbery polymer such as polycaprolactone.

Apparatus and methods for stenting are provided comprising a stent attached to a porous biocompatible material that is permeable to endothelial cell ingrowth, but impermeable to release of emboli of predetermined size. Preferred stent designs are provided, as well as preferred manufacturing techniques. Apparatus and methods are also provided for use at a vessel branching. Moreover, embodiments of the present invention may comprise a coating configured for localized delivery of therapeutic agents. Embodiments of the present invention are expected to provide enhanced embolic protection, improved force distribution, and improved recrossability, while reducing a risk of restenosis and thrombus formation.

A stent includes a central portion of helically wound undulations formed of struts, cylindrical end portions, and transition zones between the helical portion and the cylindrical portions. According to a first aspect of the invention, the torsional flexibility of the stent is maximized by having bridges connecting adjacent windings be interrupted by the maximum possible number of undulations. In one embodiment, each winding includes nineteen undulations around the circumference; bridges are provided every five undulations. According to a second aspect of the invention, uniform opening of the transition zone is achieved by altering the width, and thereby the flexibility, of a series of struts in accordance with their lengths. Specifically, the long transition zone struts are made wider.

An implant delivery system is disclosed. The delivery system includes an elongated member having an implant mounting location. A self-expandable implant is mounted at the implant mounting location. The implant is held in a compressed orientation by a retractable sheath. An interlock structure prevents the implant from deploying prematurely as the sheath is retracted. The interlock structure includes radio-opaque markers that identify the position of the implant.

An endovascular stent-graft (10) includes a generally tubular hourglass-shaped body (22), which is configured to assume a radially-compressed delivery configuration and a radially-expanded deployment configuration. The hourglass-shaped body (22) includes a flexible stent member (26), which includes a plurality of structural stent elements (28); and a tubular fluid flow guide (24), which includes a fabric (29), and is attached to the structural stent elements (28). The hourglass-shaped body (22) is shaped so as to define a narrow waist portion (32) longitudinally surrounded by and adjacent to wider first and second longitudinal portions (30, 34). The fabric (29) along the waist portion (32) is shaped so as to define at least first and second lateral apertures (36, 38). Other embodiments are also described.